Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Other Non-Current Assets (2019 - 2025)

Historic Other Non-Current Assets for IDEAYA Biosciences (IDYA) over the last 7 years, with Q3 2025 value amounting to $805000.0.

  • IDEAYA Biosciences' Other Non-Current Assets fell 1163.56% to $805000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $805000.0, marking a year-over-year decrease of 1163.56%. This contributed to the annual value of $805000.0 for FY2024, which is 634.08% up from last year.
  • As of Q3 2025, IDEAYA Biosciences' Other Non-Current Assets stood at $805000.0, which was down 1163.56% from $805000.0 recorded in Q2 2025.
  • IDEAYA Biosciences' 5-year Other Non-Current Assets high stood at $911000.0 for Q2 2024, and its period low was $106000.0 during Q2 2022.
  • Over the past 5 years, IDEAYA Biosciences' median Other Non-Current Assets value was $722000.0 (recorded in 2023), while the average stood at $531052.6.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first surged by 64622.64% in 2021, then plummeted by 8659.92% in 2022.
  • IDEAYA Biosciences' Other Non-Current Assets (Quarter) stood at $291000.0 in 2021, then plummeted by 63.57% to $106000.0 in 2022, then skyrocketed by 614.15% to $757000.0 in 2023, then rose by 6.34% to $805000.0 in 2024, then changed by 0.0% to $805000.0 in 2025.
  • Its Other Non-Current Assets stands at $805000.0 for Q3 2025, versus $805000.0 for Q2 2025 and $805000.0 for Q1 2025.